iShares Neuroscience and Healthcare ETF (IBRN)
NYSEARCA: IBRN · Real-Time Price · USD
33.32
+0.01 (0.03%)
Apr 6, 2026, 10:23 AM EDT - Market open
IBRN Holdings Information
IBRN is an equity ETF with a total of 87 individual holdings. The top holdings are Xenon Pharmaceuticals stock at 5.22%, Alkermes at 4.63%, Centessa Pharmaceuticals at 4.18%, Scholar Rock Holding at 4.07%, and PTC Therapeutics at 4.07%.
Total Holdings
87
Top 10 Percentage
41.62%
Asset Class
Equity
ETF Category
Health
Assets
4.98M
PE Ratio
16.48
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | XENE | Xenon Pharmaceuticals Inc. | 5.22% |
| 2 | ALKS | Alkermes plc | 4.63% |
| 3 | CNTA | Centessa Pharmaceuticals plc | 4.18% |
| 4 | SRRK | Scholar Rock Holding Corporation | 4.07% |
| 5 | PTCT | PTC Therapeutics, Inc. | 4.07% |
| 6 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.95% |
| 7 | AXSM | Axsome Therapeutics, Inc. | 3.93% |
| 8 | PRAX | Praxis Precision Medicines, Inc. | 3.89% |
| 9 | NBIX | Neurocrine Biosciences, Inc. | 3.87% |
| 10 | ARGX | argenx SE | 3.81% |
| 11 | ACAD | ACADIA Pharmaceuticals Inc. | 3.77% |
| 12 | BIIB | Biogen Inc. | 3.74% |
| 13 | DNTH | Dianthus Therapeutics, Inc. | 3.41% |
| 14 | SUPN | Supernus Pharmaceuticals, Inc. | 3.15% |
| 15 | DNLI | Denali Therapeutics Inc. | 3.04% |
| 16 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.04% |
| 17 | EWTX | Edgewise Therapeutics, Inc. | 2.71% |
| 18 | DYN | Dyne Therapeutics, Inc. | 2.56% |
| 19 | SRPT | Sarepta Therapeutics, Inc. | 2.42% |
| 20 | KRX: 326030 | SK Biopharmaceuticals Co., Ltd. | 1.94% |
| 21 | AXGN | Axogen, Inc. | 1.88% |
| 22 | HLBBF | H. Lundbeck A/S | 1.84% |
| 23 | CAPR | Capricor Therapeutics, Inc. | 1.66% |
| 24 | STO: BIOA.B | BioArctic AB (publ) | 1.38% |
| 25 | BHVN | Biohaven Ltd. | 1.21% |
As of Mar 31, 2026